Abbott Laboratories buy UBS Group AG
Start price
20.04.23
/
50%
€102.04
Target price
20.04.24
€118.42
Performance (%)
-1.53%
End price
21.04.24
€100.48
Summary
This prediction ended on 21.04.24 with a price of €100.48. With a performance of -1.53%, the BUY prediction by UBS_Group_AG finished with a loss. UBS_Group_AG has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Dividends of €1.96 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | -0.946% | -0.946% | -2.536% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $117.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€113.50
23.01.25
23.01.25
€142.08
23.01.26
23.01.26
-5.82%
13:37
13:37
Stopped prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€108.52
17.10.24
17.10.24
€134.85
17.10.25
17.10.25
1.35%
18.10.25
18.10.25